These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1591573)

  • 21. The relationship between serotonergic function and the Psychopathy Checklist: Screening Version.
    Dolan MC; Anderson IM
    J Psychopharmacol; 2003 Jun; 17(2):216-22. PubMed ID: 12870570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central serotonergic hyperresponsivity in late-onset Alzheimer's disease.
    McLoughlin DM; Lucey JV; Dinan TG
    Am J Psychiatry; 1994 Nov; 151(11):1701-3. PubMed ID: 7943465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders. Correlation with increased serotonergic responsivity.
    Myers JE; Mieczkowski T; Perel J; Abbondanza D; Cooper TB; Mann JJ
    Biol Psychiatry; 1994 Jan; 35(2):112-20. PubMed ID: 8167207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome.
    Yatham LN; Morehouse RL; Chisholm BT; Haase DA; MacDonald DD; Marrie TJ
    Can J Psychiatry; 1995 Mar; 40(2):93-6. PubMed ID: 7788624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of temperament and behaviour measures to the prolactin response to fenfluramine in depressed men.
    Mulder RT; Joyce PR
    Psychiatry Res; 2002 Apr; 109(3):221-8. PubMed ID: 11959359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Am J Psychiatry; 1997 Oct; 154(10):1430-5. PubMed ID: 9326827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial correlates of reduced central serotonergic system function in patients with personality disorders.
    Coccaro EF; Silverman JM; Klar HM; Horvath TB; Siever LJ
    Arch Gen Psychiatry; 1994 Apr; 51(4):318-24. PubMed ID: 8161292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin response to dl-fenfluramine in panic disorder.
    Apostolopoulos M; Judd FK; Burrows GD; Norman TR
    Psychoneuroendocrinology; 1993; 18(5-6):337-42. PubMed ID: 8416044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine and amine responses to D,L-fenfluramine in normal subjects.
    Mitchell PB; Smythe GA
    Psychiatry Res; 1991 Nov; 39(2):141-53. PubMed ID: 1686811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.
    FitzGerald M; Malone KM; Li S; Harrison WM; McBride PA; Endicott J; Cooper T; Mann JJ
    Am J Psychiatry; 1997 Apr; 154(4):556-8. PubMed ID: 9090347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.
    Mann JJ; Malone KM; Diehl DJ; Perel J; Cooper TB; Mintun MA
    Am J Psychiatry; 1996 Feb; 153(2):174-82. PubMed ID: 8561196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK; Apostolopoulos M; Burrows GD; Norman TR
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic and serotonergic receptor responsiveness in depression.
    Siever LJ; Coccaro EF; Benjamin E; Rubinstein K; Davis KL
    Ciba Found Symp; 1986; 123():148-63. PubMed ID: 3816411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients.
    Shapira B; Reiss A; Kaiser N; Kindler S; Lerer B
    J Affect Disord; 1989; 16(1):1-4. PubMed ID: 2521644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
    Cleare AJ; Bond AJ
    Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.